Sorrento Therapeutics Inc (SRNE)

[dia76ca]

COVIDROPS UK study completed in MARCH 2022 (if not earlier!).
Estimated Enrollment : 350 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19
Actual Study Start Date : July 18, 2021
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : March 2022